Scholarlink

Background <p><i>Cis</i>-regulatory elements (CREs) control oncogene expression and malignant phenotypes. The high clinicopathological heterogeneity of cancer cannot be explained by gene expression alone, being attributed to CRE heterogeneity. However, characterizing cancer-associated CREs is challenging. To address this issue, we performed a single-cell epigenomic analysis of clinical specimens.</p> Methods <p>To map the multicellular ecosystem of breast cancer (BC) and identify candidate CREs (cCREs), we performed a single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) of 38 prospectively collected BC samples with various clinicopathological characteristics.</p> Results <p>First, we performed single-cell chromatin accessibility profiling of a high-quality set of 22,775 cells from BC samples. Cells were annotated using marker gene accessibility and integration with existing single-cell RNA sequencing data. The chromatin accessibility patterns exhibited by cancer cells were consistent with the clinicopathological features of each tumor. We identified 224,585 cCREs across the BC ecosystem. By identifying cluster-specific differentially accessible cCREs (DA-cCREs) and constructing a putative enhancer–promoter network, we mapped the <i>cis</i>-regulatory landscape for cancer cells and the tumor microenvironment. The accessibility of putative enhancers targeting the same gene differed within or between tumors, highlighting intra- and inter-<i>cis</i>-regulatory tumor heterogeneity.</p> Conclusions <p>This study provides a valuable resource for future epigenetic research on BC and highlights the diverse regulatory landscape within or among tumor(s), suggesting that cCREs regulate intra- and intertumor heterogeneity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Chisa Hori,
  • Kohei Kumegawa,
  • Sumito Saeki,
  • Yoko Takahashi,
  • Liying Yang,
  • Tomoyoshi Nakadai,
  • Kazutaka Otsuji,
  • Chikako Takahata,
  • Yukinori Ozaki,
  • Natsue Uehiro,
  • Yurie Haruyama,
  • Tomo Osako,
  • Toshimi Takano,
  • Seiichi Mori,
  • Tetsuo Noda,
  • Satoshi Fujii,
  • Shinji Ohno,
  • Takayuki Ueno,
  • Reo Maruyama

摘要

Background

Cis-regulatory elements (CREs) control oncogene expression and malignant phenotypes. The high clinicopathological heterogeneity of cancer cannot be explained by gene expression alone, being attributed to CRE heterogeneity. However, characterizing cancer-associated CREs is challenging. To address this issue, we performed a single-cell epigenomic analysis of clinical specimens.

Methods

To map the multicellular ecosystem of breast cancer (BC) and identify candidate CREs (cCREs), we performed a single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) of 38 prospectively collected BC samples with various clinicopathological characteristics.

Results

First, we performed single-cell chromatin accessibility profiling of a high-quality set of 22,775 cells from BC samples. Cells were annotated using marker gene accessibility and integration with existing single-cell RNA sequencing data. The chromatin accessibility patterns exhibited by cancer cells were consistent with the clinicopathological features of each tumor. We identified 224,585 cCREs across the BC ecosystem. By identifying cluster-specific differentially accessible cCREs (DA-cCREs) and constructing a putative enhancer–promoter network, we mapped the cis-regulatory landscape for cancer cells and the tumor microenvironment. The accessibility of putative enhancers targeting the same gene differed within or between tumors, highlighting intra- and inter-cis-regulatory tumor heterogeneity.

Conclusions

This study provides a valuable resource for future epigenetic research on BC and highlights the diverse regulatory landscape within or among tumor(s), suggesting that cCREs regulate intra- and intertumor heterogeneity.